Remix Therapeutics Claimed Company
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether. These are innovative therapeutic solutions with the potential to address disease drivers at their origin. read more
Remix Therapeutics Company Culture
Remix Therapeutics Culture
This score is derived from employee ratings & reviewsChoice Employer
A
4.5/5
Top Rated Culture Dimensions
CEO Rating
A+Compensation
A+Executive Team
A+Happiness
A+Leadership
A+Remix Therapeutics CEO
Top 5%Top 5% of Similar Size Companies on Comparably
Pete Smith
91 /100
See More
Diversity at Remix Therapeutics
Top 30%Top 30% of Similar Size Companies on Comparably
B
Diverse employees at Remix Therapeutics have rated Team, Executive Team, and Happiness as the highest categories they have scored
Women at Remix Therapeutics
Top 20%Top 20% of Similar Size Companies on Comparably
B+
Women at Remix Therapeutics have rated Compensation, Happiness, and Team as the highest categories they have scored
Remix Therapeutics eNPS
Net Promoter Score tracks your employees' overall score to this question: "On a scale from 0-10, how likely are you to recommend working at your company to a friend?"Top 5%Top 5% of Similar Size Companies on Comparably
Recommend to a Friend?
85
Remix Therapeutics employees are 85% more likely to recommend Remix Therapeutics as a great place to work
| 85% | Promoters |
|---|---|
| 15% | Passives |
| 0% | Detractors |
Remix Therapeutics Company News
Remix Therapeutics Closes $70 Million Series B Financing
June 27th, 2022June 26th, 2022June 28th, 2022
https://www.remixtx.com/remix-therapeutics-closes-70-million-series-b-financing/
Remix Therapeutics Closes $70 Million Series B Financing - Remix Therapeutics
Supports Novel Small Molecule Therapeutic Approach Designed to Reprogram RNA Processing and Modulate Gene Expression Cambridge, Mass. (May 17, 2022) – Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, today announced the close of a $70 million Series B financing. Surveyor…
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
February 17th, 2022February 16th, 2022February 18th, 2022
https://www.prnewswire.com/news-releases/remix-therapeutics-names-peter-smith-phd-as-president-and-chief-executive-officer-301356806.html CAMBRIDGE, Mass., Aug. 17, 2021 /PRNewswire/ -- Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, today announced that Peter Smith, PhD, Co-Founder, President and Chief Scientific Officer of Remix,
Remix Therapeutics Appoints Zaven Kaprielian, Ph.D., as Chief Scientific Officer
February 17th, 2022February 16th, 2022February 18th, 2022
https://www.globenewswire.com/news-release/2021/12/15/2352562/0/en/Remix-Therapeutics-Appoints-Zaven-Kaprielian-Ph-D-as-Chief-Scientific-Officer.html CAMBRIDGE, Mass., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA processing and address the underlying drivers of disease, today announced the appointment of Zaven Kaprielian, Ph.D., as Chief Scientific Offi
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics
February 17th, 2022February 16th, 2022February 18th, 2022
FEB. 17, 2022, 7:00 AM EST
https://www.remixtx.com/remix-therapeutics-enters-collaboration-with-janssen-to-advance-small-molecule-therapeutics-using-remaster-drug-discovery-platform-to-modulate-rna-processing/ Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
Cambridge, Mass. (February 17, 2022) – Remix Therapeutics (Remix), a biotechnolo
Working at Remix Therapeutics
Working at Remix Therapeutics is rated highly by 35 employees, across various culture dimensions. Remix Therapeutics employees are most satisfied about CEO Rating, Compensation, and Executive Team categories, putting Remix Therapeutics’s culture in the Top 10% compared to similar sized companies on Comparably and in the Top 5% compared to other companies in Boston. See below in detail how working at Remix Therapeutics was rated by employees.
Overall Company Culture at Remix Therapeutics
A
Overall Company Culture at Remix Therapeutics is rated A
Last updated months ago
Top
10%
Remix Therapeutics ranks in the Top 10% of other companies on Comparably with 51-200 Employees for Overall Company Culture Score
Remix Therapeutics Employee Reviews
Out of 118 Remix Therapeutics employee reviews, 98% were positive. The remaining 2% were constructive reviews with the goal of helping Remix Therapeutics improve their work culture.
| Positive Reviews | 98% |
|---|---|
| Constructive Feedback | 2% |
Positive Reviews From Remix Therapeutics Employees
- What is the best part about your compensation package?very competitive with other companies, its clear they want to do right by us
- What do you like best about the leadership team?The leadership team is very approachable despite their busy schedule; they make every effort to engage with everyone in the company and put great emphasis on teamwork and collaborative science
- What makes you most happy at work?I am always learning and growing. I feel like this is great for my overall career but also my energy levels. I'm happy when I'm learning.
Constructive Feedback From Remix Therapeutics Employees
- Why do you feel undervalued and what would make you feel better about your compensation?A salary boost based on merit/performance
Remix Therapeutics Company Information
Remix Therapeutics Company Overview
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether. These are innovative therapeutic solutions with the potential to address disease drivers at their origin.
Remix Therapeutics was founded in 2019 and its current CEO is Pete Smith. Since its inception 7 years ago, Remix Therapeutics has grown to 60 employees.
Remix Therapeutics Mission, Vision & Values
Remix Therapeutics Vision Statement
Reprogramming RNA to transform patients' lives.
Remix Therapeutics Mission & Values
- True to Our RNA: We do the right thing even when no one is watching. We follow the data, are passionate, candid, and deliver on our commitments.
- Remixing Together: We celebrate diverse perspectives, support one another through successes and failures and believe every employe
- Courageous Curiosity: We push beyond traditional boundaries, ask incisive questions, learn from failure and innovate relentlessly.
| Headquarter | 100 Forge Rd Watertown, MA 02472 United States of America |
|---|---|
| Website | www.remixtx.com/ |
| Founding Date | 2019 |
| Company Status | Private |
| Jobs | www.remixtx.com/join-us/ |
| Social Sites |
Remix Therapeutics Employees
Remix Therapeutics has 60 employees. 35 employees at Remix Therapeutics have reviewed Remix Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Overall, the 35 Remix Therapeutics employees give their leadership a grade of A+, or Top 5% of similar size companies on Comparably. This includes specific ratings of their executive team, CEO, and manager.
Employees at Remix Therapeutics are extremely happy with their total compensation at Remix Therapeutics, which includes a combination of pay, stock and equity, and benefits.
Overall, employees at Remix Therapeutics are extremely happy with their team. 35 Participants grade the quality of their coworkers an A+. The majority believe the meetings at Remix Therapeutics are effective, and the majority look forward to interacting with their coworkers.
The majority of employees at Remix Therapeutics believe the environment at Remix Therapeutics is positive. Most Participants believe the pace of work at Remix Therapeutics is comfortably fast. About 38% of the employees at Remix Therapeutics work 8 hours or less.
Overall, the employees at Remix Therapeutics are extremely happy, based on their aggregated ratings of future outlook, customer perception, and their excitement going to work.
A Day in the Life
A Day in the Life
Remix Therapeutics employees generally work 9.4 hrs a day
Work Hours
A Day in the Life
Employees at Remix Therapeutics report the work pace is comfortably fast
Work Pace
A Day in the Life
100% of Remix Therapeutics employees look forward to interacting with their team every day
Coworkers
A Day in the Life
Remix Therapeutics employees most often take 20-30 paid vacation and sick days each year
Perks & Benefits
A Day in the Life
81% of Remix Therapeutics employees report they are happy with their work life balance
Work Life Balance
A Day in the Life
Remix Therapeutics employees typically get valuable feedback on how to improve at work Once a month
Feedback
A Day in the Life
100% of Remix Therapeutics employees call their work environment positive
Environment
Joining Remix Therapeutics - Employee Onboarding
The prevailing opinion from Comparably users in Boston about their company is that it was very prepared on their first day. Boston employees concluded that their overall onboarding experience was positive. 75% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
Remix Therapeutics KPIs and OKRs
Employees’ understanding of Remix Therapeutics' KPIs and OKRs is essential for its success. Out of 32 Remix Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 32 have said yes.
Are your company's goals clear, and are you invested in them?
Are the KPIs/OKRs for your department clear?
Featured Press for Remix Therapeutics
Remix Therapeutics CEO & Leadership
Remix Therapeutics CEO - Pete Smith
91 /100
Remix Therapeutics’s CEO Pete Smith started in this role in 2019. Pete’s approval rate is in the Top 5% of all CEOs of similar-sized companies on Comparably, and in the Top 5% compared to the CEOs of all other companies in Boston. Remix Therapeutics’s CEO is highly regarded especially by employees in the Biomolecular Sciences and Lead Discovery department, employees in the Chemistry department, and Caucasian employees. However, employees in the Discovery Biology department, Female employees, and employees in the Bioinformatics and Data Science department have a less favorable view of the CEO and believe there is room for improvement. Compared to Remix Therapeutics’s competitors, Pete Smith ranks right above Novartis Pharmaceuticals CEO Vas Narasimhan. Under Smith’s leadership, Remix Therapeutics employee respondents are most happy about their Compensation and the company’s Executive Team. Diversity and Environment are two areas, according to respondents, where Remix Therapeutics could stand to see real improvement.
Remix Therapeutics Leadership
The Remix Therapeutics Executive Team is rated an “A+” and led by CEO Pete Smith, Chief Business Officer/ Chief Operating Officer Heather Wasserman, and Chief Scientific Officer Zaven Kaprielian
Pete Smith CEO / President
Pete is Co-Founder and Chief Executive Officer of Remix Therapeutics. He brings extensive drug discovery experience to... read more
Heather Wasserman Chief Business Officer/ Chief Operating Officer
Heather is responsible for corporate business development and operations at Remix. She joins after 7 years at Eli Lilly,... read more
Zaven Kaprielian Chief Scientific Officer
Zaven is Chief Scientific Officer of Remix Therapeutics. He brings extensive research and drug discovery experience, as... read more
Dom Reynolds Senior Vice President, Drug Discovery
As head of chemistry, Dominic is stoked to be a part of building Remix from the ground up, leading the design and... read more
Mike Seiler Senior Director, Bioinformatics and Data Science
Heading up computational biology, Michael brings a passion for RNA biology and processing to the Remix team. He joins... read more
Fred Vaillancourt, Senior Vice President, Biomolecular Sciences and Lead Discovery
Fred oversees the biomolecular sciences, screening and lead discovery effort at Remix Therapeutics. He joins the team... read more
Remix Therapeutics Salaries
How much does Remix Therapeutics pay?
How much do people at Remix Therapeutics get paid? See the latest salaries by department and job title. The average estimated annual salary, including base and bonus, at Remix Therapeutics is $65,948, or $31 per hour, while the estimated median salary is $126,504, or $60 per hour.
At Remix Therapeutics, the highest paid job is a Sales Manager at $128,358 annually and the lowest is a Receptionist at $41,043 annually. Average Remix Therapeutics salaries by department include: Finance at $48,621, Customer Support at $66,576, Sales at $104,230, and Marketing at $73,741. Half of Remix Therapeutics salaries are above $126,504.
34 employees at Remix Therapeutics rank their Compensation in the Top 5% of similar sized companies in the US (based on 71 ratings) while 34 employees at Remix Therapeutics rank their Perks And Benefits in the Top 15% of similar sized companies in the US (based on 65 ratings).
Last updated months ago.
| Summary | Salary Range | Percentile |
|---|---|---|
1st Percentile $63k | $63k | 1st Percentile |
20th Percentile $81k | $81k | 20th Percentile |
40th Percentile $119k | $119k | 40th Percentile |
60th Percentile $188k | $188k | 60th Percentile |
80th Percentile $234k | $234k | 80th Percentile |
100th Percentile $326k | $326k | 100th Percentile |
$65,948*
Average Compensation
$126,504*
Median Compensation
* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.
Remix Therapeutics Salaries by Department
Diversity & Inclusion at Remix Therapeutics
Diverse employees at Remix Therapeutics score the company 86/100 across various culture categories, placing Remix Therapeutics in the Top 30% of companies on Comparably with 51-200 Employees for Comparably's diversity score. The Diversity score provides insights into how diverse employees feel and rate their work experience at Remix Therapeutics across various culture dimensions.
Ranked Culture the Highest
Ranked Culture the Lowest
Remix Therapeutics Perks & Benefits
We have company wide shut-downs between Christmas and New Year's and also 4th of July week. We find everyone gets to rest more because people are not Slacking, emailing, etc. while others are on vacation.
Health & Wellness
- Dental Insurance
- Vision Insurance
- Health Insurance
- Life Insurance
- Gym Membership / Reimbursement
Paid Time Off
- PTO / Vacation Policy
- Paid Holidays
- Maternity / Paternity Leave
Financial Benefits
- 401K / Retirement Plan
- Performance Bonus
Office Perks
- Company Social Outings
- Work From Home Policy
- Unique Office Space
Remix Therapeutics PTO
Remix Therapeutics' PTO and Vacation policy typically gives 20-30 days off a year.
Other than healthcare, which of the following benefits is most important to you?
Does your boss expect you to work when you're on vacation?
What do you estimate the cash value of your benefits to be? Healthcare, PTO, etc?
Frequently Asked Questions regarding Remix Therapeutics
What is Remix Therapeutics address?
Remix Therapeutics location is at 100 Forge Rd
Who is the CEO of Remix Therapeutics?
Remix Therapeutics CEO is Pete Smith, their score by employees is 91
What is Remix Therapeutics eNPS?
The eNPS for Remix Therapeutics is 85
What is the salary for Sales Manager in Remix Therapeutics?
Sales Manager average salary in the US is 128k
What are the salaries in the Finance in Remix Therapeutics?
The average salaries for Finance in Remix Therapeutics is 49k
×